Zobrazeno 1 - 10
of 122
pro vyhledávání: '"S. Maybaum"'
Autor:
Jeffrey T. Kuvin, Gregory T. Gibson, S. Maybaum, David T. Majure, Taisia Vitkovski, Shahryar G. Saba, Alan R. Hartman, Frank Breuer
Publikováno v:
Echocardiography. 38:1641-1646
Eosinophilic myocarditis, a rare and under-recognized disease process, occurs due to cytotoxic inflammation of the endomyocardium that over time may lead to a restrictive cardiomyopathy. We report clinical, multimodality imaging, and pathologic findi
Publikováno v:
The Journal of Heart and Lung Transplantation. 42:S333
Autor:
Kenneth B. Margulies, J. Um, Emma J. Birks, Randall C. Starling, Brian D. Lowes, Christopher Cunningham, Craig H. Selzman, J.E. Rame, David J. Farrar, Jaimin R. Trivedi, Stavros G. Drakos, Snehal R. Patel, Daniel J. Goldstein, Pavin Alturi, Josef Stehlik, S. Maybaum, Mark S. Slaughter
Publikováno v:
Circulation
Background: Left ventricular assist device (LVAD) unloading and hemodynamic support in patients with advanced chronic heart failure can result in significant improvement in cardiac function allowing LVAD removal; however, the rate of this is generall
Publikováno v:
The Journal of Heart and Lung Transplantation. 41:S323-S324
Publikováno v:
The Journal of Heart and Lung Transplantation. 41:S65
Autor:
Kathryn Malhame, Vanesa Bijol, Fran Wallach, Syed T. Hussain, Rebecca M. Thomas, Alex K. Williamson, H. Fernandez, Sirish Vullaganti, Samit K. Shah, Kristine Jang, S. Maybaum, Gregory T. Gibson, Michael J. Esposito, Tawfiqul Bhuiya, Brian Lima, David T. Majure, Gerin R. Stevens
Publikováno v:
Transplant Infectious Disease
Background The impact of COVID‐19 on heart transplant (HTx) recipients remains unclear, particularly in the early post‐transplant period. Methods We share novel insights from our experience in five HTx patients with COVID‐19 (three within 2 mon
Autor:
H. Fernandez, S. Maybaum, K. Malhame, Gerin R. Stevens, E. Miller, David T. Majure, James Taylor, Brian Lima, K. Davidson, M. Elyasi, G. Gibson, K. Kennedy, A. Knisel
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:S158-S159
Purpose Inflammation has been implicated in frailty seen in heart failure (HF), and macrophage migration inhibitory factor (MIF) has been associated with worse outcomes in HF. Assessment of frailty is key in determining eligibility for advanced thera
Autor:
E. Koss, D.T. Majure, Brian Lima, S. Maybaum, K. Davidson, B. Rutkin, Sirish Vullaganti, Samit K. Shah, S. Wilson, S. Vatsia, Gerin R. Stevens, H. Fernandez
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S520
Introduction Mitral regurgitation (MR) often co-exists with severe left ventricular (LV) systolic dysfunction and there is controversy regarding the need for corrective surgery at the time of left ventricular assist device (LVAD) implantation as it o
Autor:
Craig H. Selzman, J. Um, Snehal R. Patel, Emma J. Birks, J. Stehlik, Pavan Atluri, S. Maybaum, D. Farrar, Mark S. Slaughter, Daniel J. Goldstein, J.E. Rame, Jaimin R. Trivedi, Stavros G. Drakos, Randall C. Starling, M. Yin, C. Cunnigham, Kenneth B. Margulies, Brian D. Lowes
Publikováno v:
Publons
Purpose The RESTAGE-HF multicenter study demonstrated high rates of myocardial recovery after combining LVAD support with HF pharmacological therapy and regular cardiac function monitoring protocol. We sought to investigate whether the time course of
Autor:
Brian Lima, S. Maybaum, R. Vuthoori, C. Heaney, Kevin Kennedy, David T. Majure, Jessica Navarro, H. Fernandez, Gerin R. Stevens, James Taylor, K. Davidson
Publikováno v:
Journal of Cardiac Failure. 25:S163-S164
Introduction Most heart failure (HF) programs use a subjective provider assessment (SPA) of frailty, or “eye-ball” test, for patient selection for advanced therapies (AT). The Modified Fried Frailty Index (mFFI) is an objective assessment of frai